UNSPSC 51241132: Demecarium bromide

This classification denotes an anti-glaucoma agent and acetylcholinesterase inhibitor with the molecular formula C32H52N4O4.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61D5V4OKTP, chemically known as n,n-bis(3-trimethylammoniumphenoxycarbonyl)-n,n-dimethyldecamethylenediamine dibromide but more generally known as demecarium bromide, which bears US NIH Compound Identifier 5965. European Medicines Agency schedules Demecarium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06962MIG.

UNSPSC 51241132 Demecarium bromide is a Commodity code covering a pharmaceutical preparation — specifically, an anticholinesterase agent used in ophthalmic and neurological clinical settings. State and local governments procure this drug through health departments, public health clinics, hospital systems, and correctional health programs. The solicitations under this code reflect narrow, specialized demand tied to specific diagnostic or therapeutic protocols rather than broad commodity purchasing; issuing bodies typically issue RFQs or purchase orders through standing pharmaceutical contracts or cooperative purchasing agreements rather than competitive sealed bids.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted opportunities, the geographic spread and current market activity cannot be characterized from available procurement records.